CQC-regulated clinics & online consultations
Posted on October 22, 2026 by Sally-Anne Turner
You've been on weight loss injections for a few months now. The results have been good – you've lost weight, your diabetes control has improved, and your knees hurt less when you climb stairs. But now you're wondering: how long will I need to stay on this medication? Can I stop once I reach my goal weight? Will the weight come straight back if I do? These questions matter, particularly if you're over seventy and thinking about the long-term implications of continued treatment.
The evidence suggests that many people benefit from continuing weight loss injections long-term to maintain their results. This isn't what everyone wants to hear, but understanding why this is the case – and what your options really are – helps you make informed decisions about your treatment. The relationship between these medications, your body's weight regulation systems, and long-term health outcomes is more complex than simply “take it until you reach your goal weight, then stop.”
This guide explores everything you need to know about treatment duration for weight loss injections. We'll look at what the research tells us about stopping medication, why weight regain happens, what maintenance treatment involves, and the specific considerations for older adults who may face different decisions than younger people. You'll also learn about strategies that may support weight maintenance if your treatment changes, and how to make the right choice for your individual circumstances.
Before we discuss treatment duration, it's important to understand why your body can fight so hard to regain lost weight. Researchers sometimes describe this using the concept of a “biological set point” – a weight range that your body may defend through multiple hormonal and metabolic mechanisms. It's a useful way of explaining weight regulation, although the science is more complex than a single fixed weight. This isn't simply about willpower or discipline.
When you lose weight, your body can respond by increasing hunger signals, changing hormones involved in appetite regulation, such as ghrelin and leptin, and reducing the energy it uses. Some of these adaptations can persist long after weight loss, making maintenance difficult. Age-related changes in muscle mass and activity levels can add further challenges.
GLP-1 medications like Wegovy work by influencing some of these biological processes. They reduce appetite signals, increase feelings of fullness, and support weight management alongside dietary changes and physical activity. When you stop the medication, its appetite-regulating effects gradually wear off. Hunger may increase, you may think about food more often, and maintaining your lower weight can become harder.
This doesn't mean you're destined to take medication forever or that you've failed if you need ongoing treatment. It means we're working with your biology rather than relying on willpower alone. For many people, particularly those who've struggled with weight for decades, ongoing medication support may be appropriate when the benefits continue to outweigh the risks.
Research into what happens when people stop weight loss injections provides useful information for decisions about treatment duration. Several studies have followed participants after discontinuing GLP-1-based medications, although individual responses vary and older adults are not always well represented in clinical trials.
The STEP 1 extension trial, which followed people who took semaglutide for 68 weeks and then stopped, found that participants regained approximately two-thirds of their previous weight loss within one year of discontinuing treatment. Participants had lost an average of around 17% of their body weight during treatment and regained approximately 11 percentage points over the following year.
A similar pattern emerged in the SURMOUNT-4 trial studying tirzepatide (Mounjaro). Participants who switched from tirzepatide to placebo after an initial treatment period experienced substantial weight regain, while those who continued treatment generally maintained or increased their weight loss. Some improvements in cardiometabolic risk factors, including blood pressure and blood sugar measures, also moved back towards baseline after treatment stopped.
This weight regain isn't uniform across all people. Some individuals regain weight more quickly than others, while some maintain a greater proportion of their weight loss. However, the findings show why ongoing support and a realistic maintenance plan are important when considering stopping treatment.
Weight regain after stopping GLP-1 medications is partly related to the return of appetite and food-related signals as the medication leaves your system. Meanwhile, the body's adaptations to weight loss can continue, making it harder to maintain a lower weight.
For older adults, additional factors may contribute to weight regain. Age-related changes in body composition, reduced physical activity capacity, and the natural tendency to lose muscle mass as we age can make weight maintenance more challenging. If you've reduced your activity level during weight loss due to side effects or other factors, you may find it particularly difficult to maintain results without medication support.
The psychological aspect also matters. Many people find that food becomes more appealing and cravings return once the medication's appetite-suppressing effects wear off. The mental energy required to manage food choices can feel exhausting, leading to gradual increases in portion sizes and snacking frequency.
If you decide to continue weight loss injections long-term, it's helpful to understand what maintenance treatment actually looks like. It's not necessarily the same as the active weight loss phase, and your medical team should review whether treatment remains suitable as your needs change.
During the weight loss phase, the dose is usually increased gradually according to the specific medication's prescribing instructions, taking account of effectiveness and tolerability. Once you've achieved your health goals – whether that's a specific weight target, improved diabetes control, or better mobility – the focus may shift towards maintaining those improvements.
However, maintenance doses are not interchangeable with the lower doses used during treatment initiation. For example, the UK Wegovy Summary of Product Characteristics (SmPC) specifies 2.4 mg once weekly as its standard adult maintenance dose, with a higher 7.2 mg maintenance option for certain adults with obesity when clinically appropriate. Lower doses are used during escalation or may be considered temporarily when managing tolerability, rather than being established alternatives for routine long-term maintenance.
The process of reviewing your maintenance treatment involves careful monitoring. Your clinician will consider weight trends, appetite, side effects, nutritional intake, muscle strength and other health conditions. If a dose adjustment is appropriate, it should follow the medication's prescribing information and be made under medical supervision. You should not reduce or increase your dose independently.
Long-term treatment may require less frequent monitoring than the initial months of therapy, but regular check-ins remain important. The frequency of appointments depends on the medication, your health conditions, your response to treatment and any monitoring requirements.
For older adults, particularly those over seventy, closer monitoring may be appropriate. Kidney function can be important, especially if you have existing kidney disease or develop dehydration from vomiting or diarrhoea. GLP-1 medicines are not simply processed through the kidneys in a way that means age-related kidney decline automatically requires a dose reduction. However, dehydration can worsen kidney function and may require urgent assessment. Blood pressure and diabetes control should also be reviewed regularly, as your other medications may need adjusting.
These ongoing appointments provide an opportunity to discuss any concerns, review nutrition and physical activity, and assess whether the benefits of treatment continue to outweigh potential risks. For older adults, preserving strength and independence should remain central to the plan.
The financial aspect of long-term treatment is a practical consideration that deserves honest discussion. Weight loss injections are available through the NHS for eligible patients, although access depends on the specific medicine, NICE recommendations and local service arrangements. Many people who do not meet NHS eligibility criteria pay privately for treatment. Over months and years, this cost adds up significantly.
When weighing the financial cost, consider the broader picture of your health. Weight loss may improve diabetes control, blood pressure or joint symptoms, potentially allowing a clinician to review some existing medications. However, reducing or stopping these medicines is not guaranteed and should never be done without medical advice.
Some people choose to discuss stopping treatment after achieving significant weight loss, knowing that weight regain is possible. This may reduce medication costs, but it also requires a plan for monitoring and maintaining their health. For others, the benefits of continued treatment justify the ongoing expense. The decision should be based on clinical suitability as well as affordability.
While many people benefit from ongoing medication to maintain weight loss, there are strategies that can support long-term weight management whether treatment continues, changes or stops. None guarantees that you'll be able to discontinue medication entirely, but they can improve your overall health and help you maintain progress.
The time you spend on weight loss medication isn't just about losing weight – it's an opportunity to establish new habits and patterns that may help you maintain results. While the medication reduces appetite and can make dietary changes easier, use this period to develop skills and routines that support your long-term health.
Focus on recognising hunger and fullness signals while also ensuring you're eating enough. This is particularly important for older adults, as excessive appetite suppression can contribute to inadequate nutrition and muscle loss.
Establish regular eating patterns that work for you. Some people do well with three meals daily, while others prefer smaller, more frequent meals. Find protein sources you enjoy and can prepare easily. Develop a repertoire of healthy meals you actually like eating, not just foods you think you “should” eat. The goal is creating patterns you could realistically maintain long-term, not following a restrictive diet that requires constant willpower.
Regular physical activity is an important part of maintaining weight loss, regardless of whether you continue medication. Exercise helps preserve muscle mass, supports metabolic health and improves physical function. For older adults, it also helps maintain mobility, balance and independence.
The type of exercise matters. Resistance training is particularly important for preserving muscle mass and strength. You don't need to lift heavy weights at a gym – bodyweight exercises, resistance bands or light dumbbells can all be effective. Aim to include muscle-strengthening activities on at least two days each week, adapted to your abilities and medical needs.
Cardiovascular activity supports heart health, while strength and balance exercises help protect physical function. A combination is particularly valuable. Walking is an excellent option for many older adults – it's low-impact, accessible and provides both physical and mental health benefits. UK physical activity guidance recommends at least 150 minutes of moderate-intensity activity weekly for older adults where possible, alongside strength, balance and flexibility activities. If you have limited mobility or frailty, a physiotherapist can help develop a safe, individual programme.
Building exercise habits while you're on medication may make it easier to continue them if treatment changes. However, don't push through pain, dizziness or weakness. Your activity plan should support your health rather than create additional risks.
Factors beyond diet and exercise influence weight regulation, particularly as we age. Chronic stress can affect eating patterns, sleep and overall health. Poor sleep may influence appetite regulation, while menopause and post-menopausal hormonal changes can affect body composition and fat distribution.
Addressing these factors won't necessarily replace medication, but it can support your overall health. Prioritise sleep by maintaining consistent sleep and wake times, creating a comfortable sleeping environment and limiting activities that disrupt rest. Many adults need around seven to nine hours of sleep, although individual needs vary.
Manage stress through techniques that work for you – this might include meditation, gentle yoga, time in nature, social connections or hobbies you find relaxing. Chronic stress affects more than weight, so addressing it can benefit your wellbeing in several ways.
For women experiencing menopausal symptoms that affect weight management, hormone replacement therapy might be worth discussing with your doctor. HRT can help manage menopausal symptoms, including sleep disruption, but it is not licensed as a weight loss treatment and should not be prescribed solely for weight management.
The decision about how long to continue weight loss injections involves different considerations when you're over seventy compared to younger adults. Your overall health, frailty, quality of life priorities, and other medical needs all factor into what makes sense for your individual situation.
For younger adults, the decision about long-term medication often centres on preventing future health complications – reducing the risk of heart disease, diabetes complications or joint problems decades down the line. When you're in your seventies or eighties, the time horizon may be different. The question becomes: what will most improve my quality of life and health right now, as well as in the years ahead?
If weight loss has significantly improved your mobility, reduced your pain or helped improve management of other conditions, continuing treatment may be worthwhile. The benefit you're experiencing is immediate and tangible. However, if weight loss has been modest and hasn't significantly changed how you feel or function, you might reasonably question whether ongoing treatment makes sense.
Consider also the burden of treatment itself. Some people tolerate GLP-1 medications well long-term, while others continue experiencing side effects. Weekly injections require manual dexterity that may become more challenging if you develop arthritis or other conditions affecting your hands. The cost of ongoing treatment may compete with other priorities on a fixed income.
One specific concern for older adults is the relationship between weight loss and muscle mass. As discussed in our guide to weight loss injections for over-70s, preserving muscle and strength is critical for maintaining independence and reducing the risk of frailty. Weight loss can involve losing both fat and lean tissue, so adequate nutrition and appropriate physical activity matter.
If you've achieved significant weight loss but are struggling to maintain adequate protein intake or engage in regular strength training, continuing to pursue further weight loss may not be in your best interest. Maintaining your current weight while focusing on preserving muscle might be a better approach than pushing for further weight loss.
Some older adults may benefit from a revised maintenance strategy that prioritises strength, mobility and nutritional wellbeing rather than reaching the lowest possible weight. This might involve reviewing treatment goals, dietary intake and exercise support. Any changes to medication should be based on the licensed dosing guidance and an individual clinical assessment, rather than simply reducing the dose to encourage a higher calorie intake.
Many older adults take multiple medications for various conditions – a situation called polypharmacy. Each additional medication increases the complexity of your treatment regimen and the potential for interactions or side effects. When deciding whether to continue weight loss injections long-term, consider how they fit into your overall medication burden.
On one hand, successful weight loss may allow a clinician to reduce or discontinue some other medications. If your diabetes control or blood pressure has improved, your medical team may be able to review your existing treatment. However, this is not guaranteed, and medication changes must be made carefully to avoid complications such as hypoglycaemia or low blood pressure.
On the other hand, if you're still taking multiple medications despite weight loss, adding a long-term weight loss injection increases your overall medication burden. There's no single right answer here – it's about weighing what matters most for your individual situation. Some people prioritise minimising medications wherever possible, while others are comfortable with ongoing treatment if it provides clear benefits.
If you decide to stop weight loss injections – whether to see if you can maintain results without medication, due to side effects, cost concerns or any other reason – it's important to approach this transition thoughtfully. These medicines do not generally require tapering to prevent a withdrawal syndrome, but stopping can affect appetite, weight and the management of other health conditions, particularly diabetes.
Unlike some medications that must be tapered gradually to avoid withdrawal effects, GLP-1-based weight loss medicines do not routinely require a gradual reduction before stopping. However, this doesn't mean you should stop without speaking to your prescriber, especially if the medicine is also being used to manage type 2 diabetes.
There is currently insufficient high-quality evidence to recommend a standard tapering schedule as a proven way to prevent weight regain. Reducing Wegovy from 2.4 mg through lower initiation doses over several months, for example, should not be presented as an established withdrawal protocol. Those lower doses have specific roles in treatment escalation and tolerability management, and changes must be considered against the product's prescribing information.
Some people may be offered an individualised plan for stopping treatment and monitoring what happens afterwards. This might include reviewing appetite, weight, blood glucose where relevant, nutritional intake and physical function. The aim is to identify changes early and ensure you have appropriate support, rather than assuming tapering will prevent weight regain.
If you're planning to stop medication, the weeks leading up to stopping and the months immediately after are important times to review your lifestyle strategies. This doesn't mean becoming overly restrictive or exercising excessively. It means ensuring you have a sustainable plan for nutrition, movement and weight maintenance.
Before stopping, ensure you have a solid plan in place. This might include meal planning strategies, regular exercise routines you've established, and support systems to help you stay accountable. Some people find working with a dietitian during this transition helpful. Others join weight management groups or work with a physiotherapist or appropriately qualified fitness professional to maintain structure and support.
Monitoring during this transition can help you recognise changes early. You may wish to track your weight periodically, alongside appetite, strength, mobility and relevant health measures. If you notice a consistent upward trend, discuss it with your clinical team rather than waiting until substantial weight regain has occurred. For adults over seventy, avoiding malnutrition and preserving physical function remain just as important as preventing weight regain.
Some people who stop weight loss injections may later consider restarting treatment. This isn't a failure – it's a recognition that weight management needs can change. Understanding when restarting might be appropriate can help you make this decision without guilt or frustration.
If you've regained a meaningful amount of weight despite ongoing dietary and lifestyle support, it may be worth discussing treatment options again. There is no universal percentage of weight regain that automatically means you should restart medication. The decision should reflect your health, current BMI, treatment eligibility, nutritional status and personal goals.
Also consider seeking a review if health conditions that improved with weight loss begin deteriorating again. If your blood sugar control worsens, your blood pressure increases or joint pain returns, these may be signs that your overall treatment plan needs reassessing.
Finally, consider your quality of life. If stopping medication means you're constantly thinking about food, struggling with cravings or feeling deprived while trying to maintain your weight, discuss this with your medical team. If restarting is appropriate, your prescriber will need to reassess your suitability and determine the correct re-initiation dose. You should not automatically restart at the dose you were previously taking, particularly after an extended break.
There's no universal answer to how long you should stay on weight loss injections. The right decision depends on your individual circumstances, health goals, response to treatment and personal priorities. What matters is making an informed choice that aligns with your values and supports your overall wellbeing.
When thinking about treatment duration, ask yourself these questions: How significantly has weight loss improved my health and quality of life? Are the benefits I'm experiencing worth the cost and effort of ongoing treatment? What support would I need if I stopped medication?
Consider also: What are my priorities at this stage of life? Am I trying to maximise longevity, or is quality of life in the present more important? How does ongoing treatment fit with my other health needs and goals? What would concern me most about continuing or stopping treatment?
For older adults, additional questions matter: How does weight loss affect my strength, energy and independence? Am I able to maintain adequate nutrition and muscle mass while on medication? Does continuing treatment align with my overall health and life goals?
These decisions shouldn't be made in isolation. Your medical team can provide important perspective on what makes sense for your individual situation. They can help you understand how weight loss has affected your overall health, whether you've achieved meaningful improvements in medical conditions, and what the risks and benefits of continuing or stopping treatment might be.
The NICE guidance on medicines for overweight and obesity management sets out treatment-specific recommendations, including when to review effectiveness and consider stopping medication. For example, NICE advises considering stopping semaglutide if less than 5% of initial body weight has been lost after six months of treatment. For tirzepatide, if less than 5% has been lost after six months on the highest tolerated dose, clinicians should review the individual benefits and risks before deciding whether to continue. NHS treatment pathways and duration may also differ from private prescribing arrangements.
At Bodyline, our specialised support for adults over 70 includes ongoing discussions about treatment goals and duration. We recognise that what makes sense may change over time as your circumstances, health status and priorities evolve. Our role is to provide information, support and medical expertise while respecting that you're the expert on your own life and values.
Be honest with your medical team about your concerns, whether they're related to cost, side effects, injection burden or uncertainty about long-term treatment. There may be options you haven't considered, such as reviewing your treatment plan or discussing alternatives. If injections are burdensome, you might ask about the Wegovy pill, but oral and injectable semaglutide are not automatically interchangeable, and the availability, licensed indication and suitability of any oral treatment must be checked before prescribing. The MHRA's guidance on GLP-1 medicines advises patients to consult a healthcare professional before switching between these medicines. Planned treatment breaks should likewise be discussed with your prescriber rather than undertaken independently.
Finally, recognise that the decision you make now doesn't have to be permanent. You might decide to continue treatment, then later review whether it's still appropriate. Or you might stop treatment, experience weight regain, and discuss whether restarting makes sense. You may also find that changes in your health, nutrition or medication tolerance require a different approach.
All of these outcomes are possibilities. Weight management is a long-term process, and what works best may change as you age, as your health status changes or as your life circumstances evolve. The goal isn't to make a perfect decision that you'll never revisit – it's to make the best decision for right now based on the information and circumstances you have today.
Understanding that many people benefit from long-term treatment to maintain weight loss with GLP-1 medications can help you make realistic plans. These medicines influence biological processes involved in appetite and weight regulation. When their effects wear off, weight regain may occur. This is normal physiology, not personal failure.
For some older adults, ongoing medication support for weight management may be appropriate, just as long-term treatment is used for other chronic conditions. However, weight loss injections aren't automatically suitable for everyone indefinitely. The potential benefits must be balanced against side effects, nutritional risks, frailty, other medical conditions and personal preferences.
The key is ensuring that ongoing treatment continues to provide meaningful benefits that justify the cost, effort and any side effects you experience. Regular monitoring, honest conversations with your medical team, and periodic reassessment of your goals and priorities help ensure your treatment plan continues serving you well.
If you're currently on weight loss injections and wondering about your long-term plan, or if you're considering starting treatment and want to understand the full picture of what's involved, we're here to help. Book a consultation today to discuss your individual situation, explore your options, and develop a treatment plan that aligns with your health goals and personal circumstances. Our team understands the unique considerations for older adults and can provide specialised support to help you make informed decisions about your care.
Whether you're seeking treatment at one of our weight loss clinics throughout the North West or prefer the convenience of our online consultation service, we'll work with you to develop an approach that supports your health, respects your autonomy, and prioritises your quality of life.
Contact us today
Find out more about how we can treat and support you to improve your health and wellbeing.
No-obligation advice from our CQC-regulated team, in clinic or by video.
